Enanta Pharmaceuticals
ENTA
#7341
Rank
S$0.58 B
Marketcap
S$20.19
Share price
-3.08%
Change (1 day)
133.81%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: S$0.58 Billion

As of December 2025 Enanta Pharmaceuticals has a market cap of S$0.58 Billion. This makes Enanta Pharmaceuticals the world's 7341th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.58 B236.51%
2024S$0.17 B-33.84%
2023S$0.26 B-79.82%
2022S$1.29 B-37.43%
2021S$2.07 B85.37%
2020S$1.11 B-32.22%
2019S$1.64 B-12.26%
2018S$1.88 B25.28%
2017S$1.50 B62.6%
2016S$0.92 B5.16%
2015S$0.87 B-29.8%
2014S$1.25 B101.4%
2013S$0.62 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Enanta Pharmaceuticals was reported to be:

S$0.60 Billion
by Nasdaq info icon info icon
S$0.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
S$519.57 B 89,077.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$637.04 B 109,240.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$151.28 B 25,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$337.12 B 57,762.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$141.98 B 24,269.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$343.02 B 58,775.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland